NCT03698409View on ClinicalTrials.gov

Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine.

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Chronic Migraine, Headache
Interventions
DRUG

Preserved saline in reconstitution of Botox

The intervention consists of using 4 ml of preserved saline for the reconstitution of OnabotuliniumtoxinA prior to its use in subjects with chronic migraine.

Trial Locations (1)

13210

SUNY Upstate Medical University, Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT03698409 - Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine. | Biotech Hunter | Biotech Hunter